Pharmaceutical sales management system

Abstract

To provide a drug sales management system that can record drugs sold by pharmacists and present and record precautions for the drugs.SOLUTION: A drug sales management system comprises: pharmacist identification information acquisition means for acquiring identification information of a pharmacist; a drug identification information acquisition means for acquiring identification information of a drug to be sold; explanatory information acquisition means for acquiring explanatory information corresponding to the identification information of each drug acquired by the drug identification information acquisition means; explanatory information presentation means for presenting the explanatory information acquired by the explanatory information acquisition means to a sales target; presentation confirmation means for having the sales target confirm the explanatory information; and history storage means for recording, in a history database, sales history information including the identification information of the drug acquired by the drug identification information acquisition means, a sales date and time determined from a current date and time, and the identification information of the pharmacist acquired by the pharmacist identification information acquisition means, after confirmation by the presentation confirmation means.SELECTED DRAWING: Figure 1

Description

[Technical Field]

[0001] The present invention relates to a pharmaceutical sales management system, and more particularly to a pharmaceutical sales management system that can record pharmaceuticals sold and present precautions for the pharmaceuticals. [Background technology]

[0002] Among commercially available pharmaceuticals, prescription drugs and Category 1 drugs are required to be provided with information about the drug and guidance based on pharmaceutical knowledge in person by a pharmacist at the time of sale. When providing this information, pharmaceutical sellers must present explanatory information about the drug to the target customer, such as a checklist, and keep and manage records of this information. Several such systems have been studied (see, for example, Patent Documents 1 and 2). [Prior art documents] [Patent documents]

[0003] [Patent Document 1] Utility Model Registration No. 3150049 [Patent Document 2] Japanese Patent Application Laid-Open No. 2010-170218 Summary of the Invention [Problem to be solved by the invention]

[0004] Patent Document 1 describes an information provision system that reads barcodes attached to pharmaceuticals and displays corresponding usage precautions on a screen. Patent Document 2 describes a sales processing device that reads codes attached to products with a scanner and prints out instructions if necessary.

[0005] As in Patent Documents 1 and 2, systems for displaying instructions for pharmaceuticals have been considered, but whether or not guidance has been provided by a pharmacist is not recorded, and it is not possible to determine whether or not guidance has been provided. The present invention has been made in consideration of the above-mentioned problems, and aims to provide a pharmaceutical sales management system that can record pharmaceuticals sold by pharmacists, present precautions for the pharmaceuticals, and display and record information for considering combinations with other pharmaceuticals, etc. [Means for solving the problem]

[0006] The present invention is as follows. 1. A pharmacist identification information acquisition means for acquiring identification information of a pharmacist who provides pharmaceutical usage guidance; A drug identification information acquisition means for acquiring identification information of one or more of the drugs to be sold; an explanation information acquisition means for acquiring explanation information corresponding to the identification information of each drug obtained by the drug identification information acquisition means; an explanatory information presenting means for presenting the explanatory information of the drug acquired by the explanatory information acquiring means to a sales target of the drug; a presentation confirmation means for allowing the target person to confirm the explanatory information of the drug presented by the explanatory information presentation means; a history storage means for recording sales history information, including the drug identification information obtained by the drug identification information obtaining means, the sales date and time determined from the current date and time, and the pharmacist identification information obtained by the pharmacist identification information obtaining means, in a history database after confirmation by the presentation confirmation means; A pharmaceutical sales management system comprising: 2. A pharmaceutical sales management system as described in 1., wherein the pharmaceutical identification information acquisition means acquires the pharmaceutical identification information by a barcode reading means that reads a barcode on which the pharmaceutical identification information attached to the pharmaceutical is recorded. 3. A pharmaceutical sales management system as described in 1., wherein the pharmacist identification information acquisition means acquires the pharmacist's identification information using a barcode reading means that reads a barcode held by the pharmacist on which the pharmacist's identification information is recorded. 4. A pharmaceutical sales management system as described in 1. above, further comprising a sales target identification information acquisition means for acquiring the identification information of the sales target, and the history storage means records the sales history information including the identification information of the sales target acquired by the sales target identification information acquisition means in the history database. 5. A pharmaceutical sales management system according to claim 4, wherein the identification information of the sales target is an identification number of a member of a store that sells pharmaceuticals. 6. When the barcode reading means reads the identification information of the medicine, the explanation information presenting means determines whether the identification information of the pharmacist has been read, 6. The pharmaceutical sales management system according to any one of 3. to 5., wherein if the reading has been completed, the pharmaceutical sales management system presents the pharmacist's information together with the pharmaceutical explanation information to the sales target. [Effects of the Invention]

[0007] This pharmaceutical sales management system can provide sales targets with important information about specific pharmaceuticals sold in stores. It can also record pharmacists who provide face-to-face pharmaceutical instruction using identification information specific to each pharmacist, allowing for management of the provision of pharmaceutical information and instruction based on pharmaceutical knowledge. Furthermore, by referencing the history database, pharmacists can confirm which pharmaceuticals are being used by sales targets. This information can then be referenced and used by pharmacists to provide instruction to ensure the appropriate use of over-the-counter pharmaceuticals. [Brief explanation of the drawings]

[0008] The present invention will be further described in the following detailed description by way of non-limiting examples of exemplary embodiments according to the present invention and with reference to the mentioned drawings, in which like reference numerals refer to like parts throughout the several views of the drawings. [Figure 1] FIG. 1 is a block diagram for explaining the configuration of the pharmaceutical sales management system. [Figure 2] FIG. 10 is a diagram illustrating an example of explanatory information. [Figure 3] FIG. 2 is a diagram for explaining the contents of sales history information recorded in a history database. [Figure 4] 10 is a flowchart illustrating a process for recording sales history information in a history database. [Figure 5] 10 is a flowchart illustrating the flow of the pharmacist identification information acquisition means 11. [Figure 6] 10 is a flowchart illustrating the flow of the drug identification information acquisition means 21. [Figure 7] 10 is a flowchart illustrating the flow of the explanation information acquisition means 22. [Figure 8] 10 is a flowchart illustrating the flow of the presentation confirmation means 24. [Figure 9] FIG. 10 is a block diagram illustrating the configuration of another pharmaceutical sales management system. DETAILED DESCRIPTION OF THE INVENTION

[0009] The matters set forth herein are for illustrative purposes only and are intended to provide an illustrative description of the embodiments of the present invention, with the aim of providing what is believed to be the most effective and easily understandable explanation of the principles and conceptual features of the present invention. In this respect, it is not intended to show structural details of the present invention beyond the extent necessary for a fundamental understanding of the present invention, and the description, taken together with the drawings, will make clear to those skilled in the art how some aspects of the present invention may be actually embodied.

[0010] The present invention will be described in detail below with reference to the drawings. An embodiment of this pharmaceutical sales management system comprises a pharmacist identification information acquisition means 11 that acquires the identification information of a pharmacist who provides pharmaceutical usage instructions, a pharmaceutical identification information acquisition means 21 that acquires the identification information of one or more of the pharmaceuticals to be sold, an explanatory information acquisition means 22 that acquires explanatory information corresponding to the identification information of each pharmaceutical obtained by the pharmaceutical identification information acquisition means 21, an explanatory information presentation means 23 that presents the explanatory information of the pharmaceutical obtained by the explanatory information acquisition means 22 to the person to whom the pharmaceutical is to be sold, a presentation confirmation means 24 that has the person to whom the pharmaceutical is to be sold confirm the explanatory information of the pharmaceutical presented by the explanatory information presentation means 23, and a history storage means 31 that, after confirmation by the presentation confirmation means 24, records sales history information in a history database, including the identification information of the pharmaceutical obtained by the pharmaceutical identification information acquisition means 21, the sales date and time determined from the current date and time, and the identification information of the pharmacist obtained by the pharmacist identification information acquisition means 11. Also, a physical information database 33 that records physical information corresponding to the sales target identification information acquired by the sales target identification information acquisition means, and a physical information display means 34 that displays the sales target's physical information to the pharmacist and / or sales target, can be provided, and the physical information display means 34 can be activated upon presentation by the presentation confirmation means. Furthermore, the physical information database 33 and sales restriction means 35 that determines whether the sales target's physical information and the identification information of other sales targets correspond to the sales restriction information for the sales targets, and notifies the purchaser if they do, can be provided, and the sales restriction means 35 can be activated before the sales target identification information acquisition means 25 executes the history storage means 31.

[0011] The pharmaceuticals handled by this pharmaceutical sales management system include at least pharmaceuticals that require face-to-face provision of pharmaceutical information by a pharmacist at the time of sale to the target purchaser, such as prescription-only pharmaceuticals and first-class pharmaceuticals. They may also include pharmaceuticals such as second-class and third-class pharmaceuticals that do not require provision of information, as well as quasi-drugs and health foods.

[0012] The pharmacist identification information is information that identifies the pharmacist who provides pharmaceutical instruction and is recorded on an information medium carried by the pharmacist. The pharmacist identification information acquisition means 11 can acquire the pharmacist information about that pharmacist stored in the history database by any reading means of this information medium. Examples of information media include cards and accessories made of paper or plastic, on which identification information is recorded (e.g., one-dimensional barcodes and two-dimensional barcodes), RF chips, characters, magnetic straps, etc. The pharmacist's identification information can be obtained by reading this information media using a reading device such as a barcode reader, magnetic reader, camera, or magnetic card reader. Biometric information such as face, fingerprint, or iris, or password input may also be used. Furthermore, multiple pieces of identification information may be combined and used as a single pharmacist's identification information. In addition, this system can determine whether the pharmacist identification information is valid using an algorithm or pharmacist identification information stored in a database, and if the pharmacist identification information is invalid, subsequent processing can be stopped.

[0013] Drug identification information is information that can individually identify the type of drug being sold. The type of this identification information is not particularly limited, and it may be an existing identification code such as a product code assigned by the drug manufacturer, or it may be a unique code. Drugs may also be identified by product images of the drug. The drug identification information acquisition means 21 can be configured to determine whether the drug being sold is a specific drug that requires explanation and guidance of precautions to be given to the target consumer. At least prescription drugs and first-class drugs are determined to be the specific drug. In addition, the specific drug may include drugs specified by the seller.

[0014] The drug information is an explanatory document provided by a pharmacist to the intended recipient, which describes the drug's ingredients, effects, precautions, and confirmation check items, etc. The explanatory document provided to the intended recipient may be the instruction manual attached to the drug, or it may be edited and organized as items requiring explanation and confirmation, or it may include documents, drawings, images, etc. prepared by the seller. The explanatory information acquisition means 22 is only required to acquire explanatory information of a drug corresponding to drug identification information, and can acquire explanatory information of a drug, for example, by referring to a drug database 26 in which drug identification information and corresponding drug explanatory information are recorded. Alternatively, the means 22 can acquire explanatory information of a drug by referring to an external database or by individually referring to a database for each drug of a drug manufacturer or the like.

[0015] The explanatory information presenting means 23 can process the explanatory information of the drug acquired from the explanatory information acquiring means 22 into a presentable form. For example, it is possible to change the scale according to the vertical and horizontal sizes of the display means such as a display for presenting the drug explanatory information, adjust the size and layout of the characters according to the viewing distance, add buttons or the like for sequentially displaying explanatory information of multiple drugs, perform marking display and operation such as highlighting important points for the sales target, add supplements to specific keywords or codes in the drug explanatory information tailored to the sales target, add date and time calculations, etc.

[0016] When barcodes are used as the pharmacist identification information and drug identification information, any barcode (not limited to striped one-dimensional codes, but including two-dimensional codes) can be used. Furthermore, the same type of barcode can be used for the pharmacist identification information and drug identification information. When the same type of barcode is used, each barcode can be acquired by a different barcode reading means, or by a single barcode reading means. When acquired by a single barcode reading means, the pharmacist identification information and drug identification information can be acquired sequentially by determining the order in which each piece of identification information is acquired and acquiring it sequentially. Alternatively, an identification information determination means 42 can be provided to determine whether the acquired barcode value is pharmacist identification information or drug identification information, and a means corresponding to the determined identification information can be implemented. That is, if the value obtained from the barcode is determined to be pharmacist identification information, the pharmacist identification information acquisition means 11 is implemented; if the value is determined to be drug identification information, the drug identification information acquisition means 21 is implemented; and if neither is determined to be true, a read failure can be reported.

[0017] The identification information determination means 42 can determine whether the identification information is pharmacist identification information or drug identification information by using differences in the number of digits of the value consisting of numbers, characters, etc. obtained from the barcode (for example, pharmacist identification information if it is less than a specified number of digits, and drug identification information if it is more than the specified number of digits), differences in the range of values, differences in error detection codes using check digits, checksums, hash values, etc.

[0018] The means for presenting the explanatory information of the drug by the explanatory information presenting means 23 is a means for presenting the explanatory information of the drug as a document or the like to the target person for confirmation, and the display means for presentation may be a display on a terminal such as a tablet or a screen of a cash register or the like, or the printing means may be a printer or the like for printing on paper so that the printed paper can be presented. In addition, playback by a playback means for audio, video, etc. may be used in combination. The explanatory information presentation means 23 may further include a presentation confirmation means 24 that can detect whether the target person has confirmed the explanatory information of the drug. The presentation confirmation means 24 can detect whether the target person has confirmed the explanatory information of the drug by inputting an input operation such as pressing a confirmation button provided on a touch panel or button device, inputting a handwritten signature, or reading and identifying an identifiable medium such as a point card or an IC card equipped with an electronic certificate. In addition, the confirmation information used in the input operation can be stored in the history storage means 31 as sales history information.

[0019] The sales target identification information is information that can identify the sales target of the pharmaceuticals being sold. Such information can be a combination of name, address, and telephone number. Also, the sales target identification information can be the identification number of a member of a store that sells pharmaceuticals, such as a point card or a membership app. Furthermore, biometric information such as face, fingerprints, and iris can also be used as sales target identification information.

[0020] The sales target identification information acquisition means 25 is a means for acquiring the sales target identification information. The sales target identification information acquisition means 25 can acquire the sales target identification information by obtaining the sales target identification information from any input means such as a touch panel or keyboard of the terminal, or by acquiring the sales target identification information that has already been input into the POS terminal used for sales. The sales target identification information acquisition means 25 can be implemented at any timing up until the sales history information is recorded by the history storage means 31, and can be implemented simultaneously with the presentation confirmation means 24, for example. When implemented simultaneously, the confirmation information such as a signature input by the presentation confirmation means 24 can be used as the sales target identification information, eliminating the need to input it again.

[0021] The sales history information is information used for the history of pharmaceutical sales and for confirming whether information was provided by a pharmacist at the time of sales. The sales history information is also stored in the history database 32 by the history storage means 31, and sales history and guidance can be confirmed by referring to the history database 32. The sales history information includes at least the drug identification information obtained from the drug identification information acquisition means 21, the date and time of sale determined from the current date and time, and the pharmacist information obtained from the pharmacist identification information acquisition means. It can also include optional information such as sales target identification information, check items entered by the sales target, confirmation information such as a signature, and the price of the drug. Note that when this system handles drugs such as Category 2 and Category 3 OTC drugs for which information provision is not required, or other types of products such as quasi-drugs and health foods, information on the type of product can be included. The sales history information recorded in the history database 32 can be used to, for example, prevent overdose, the excessive use of medicines, in order to utilize commercially available medicines. Furthermore, since the sales history information can be used as health management information for the purchase target to check drug combinations, etc., in the same way as a medicine notebook that records prescribed medicines, the history database 32 can be used as a health management database. Furthermore, by combining it with a searchable database of over-the-counter drugs and prescription drugs with the same efficacy as the sold drug, it can be used as information for selecting and presenting over-the-counter drugs and prescription drugs with the same efficacy. The above-mentioned use can be used to present over-the-counter drugs instead of prescription drugs. It can also be used by doctors, hospitals, and pharmacies that do not handle over-the-counter drugs to know the efficacy of over-the-counter drugs, or to understand the drug usage status of target customers.

[0022] The pharmaceutical sales management system 1 may further include a sales quantity limiting means for limiting the number of pharmaceuticals sold to the same sales target to a certain number. For example, it may acquire information on the known purchase limit for a pharmaceutical product, calculate the number of pharmaceuticals purchased by the same sales target over a certain period of time from sales history information, and issue a notification if the purchase limit is exceeded. The certain period and the purchase quantity are determined based on restrictions such as the maximum allowable dose of the pharmaceutical product. If the sales target person identification information has not been acquired when the sales quantity limiting means is implemented, the sales target person identification information acquiring means can be implemented first to acquire the sales target person identification information. In addition, an equivalent drug presentation means may be provided that refers to an equivalent product database that matches the pharmaceutical product being sold with equivalent pharmaceutical products such as generic pharmaceutical products that have the same efficacy, and presents the equivalent pharmaceutical product information along with the pharmaceutical product information.

[0023] Furthermore, a physical information database 33 can be provided that records physical information corresponding to the sales target identification information acquired by the sales target identification information acquisition means. The physical information database 33 can include any information necessary for determining whether a similar drug to be sold is suitable or whether a drug is contraindicated, such as drug history, age, blood pressure, heart rate, electrocardiogram, basal body temperature (mainly for women), height, waist circumference, weight, body fat percentage, daily energy intake (calorie intake), daily step count, and related history, calculated values ​​such as BMI, allergens that cause allergic diseases, and images of food and drink eaten. Furthermore, the amount of energy intake can be calculated by analyzing images of the food and drink eaten to recognize the food and drink and its amount, and then referring to the food and drink recognition information recorded in a database and the energy amount per unit amount.

[0024] The physical information database 33 can be used for the physical information display means 34 and the sales restriction means 35. The physical information display means 34 and the sales restriction means 35 can be implemented simultaneously with the explanatory information presentation means and can be implemented simultaneously with the display of explanatory information by the explanatory information presentation means. They can also be implemented by an operator's operation while the explanatory information is being displayed. Furthermore, they can be implemented when sales target identification information is acquired by implementing the sales target identification information acquisition means. Furthermore, if sales target identification information has not been acquired when the physical information display means 34 and the sales restriction means 35 are implemented, the sales target identification information acquisition means can be implemented first to acquire the sales target identification information.

[0025] The physical information display means 34 is a means for displaying the physical information of the sales target to the pharmacist and / or the sales target. The physical information display means 34 acquires physical information corresponding to the sales target information from the physical information database 33 and displays the acquired physical information. Using this physical information, the pharmacist can refer to the physical information to select medicines to sell or to use as information for determining whether a medicine is contraindicated. It can also be used to make decisions about daily health management and lifestyle-related disease prevention. Furthermore, it can also determine whether the food, drink, or medicine you are purchasing is incompatible with other foods, drinks, or medicines, based on images of the food and drink you have eaten and the medicines you are purchasing, and notify the pharmacist. Such notifications can reduce the burden on pharmacists and can be used as educational materials for them.

[0026] The sales restriction means 35 is a means for determining whether the physical information of the person to whom the drug is sold and the identification information of other drugs sold correspond to the sales restriction information of the drug sold, and notifies the purchaser if they do. The sales restriction information of the drug to be sold is information that is stored in association with the identification information of the corresponding drug in the drug database 26. The sales restriction information can include age restriction information, allergen information, food and beverage information, etc. as restricted physical information. The age restriction information may include restriction conditions such as being under a certain age or being over a certain age, and restriction content information such as not being able to sell or having parental consent confirmed. The sales restriction means 35 can issue a notification based on the restriction content information when the medicine to be sold satisfies the restriction conditions of the sales restriction information. An example of the sales restriction means 35 is to restrict sales by age. Age-based sales restrictions can prohibit sales if the customer falls under certain conditions, such as if they are under a certain age or over a certain age, or can warn pharmacists by notifying them of parental consent confirmation. By using these conditions, pharmacists can be warned when selling adult medicines that cannot be taken by children, emergency contraceptives that require parental consent for minors, and antihistamines that require caution when taken by the elderly. The parental consent is confirmed by acquiring the parental target identification information by the parental target identification information acquiring means 25 and by inputting the parental target signature by the presentation confirming means 24.

[0027] The pharmaceutical sales management system may be configured as software executed on a terminal such as a tablet or PC, or may be a service executed on a server and accessed from the terminal. The terminal may also be provided as a function of a terminal used for sales, such as a POS terminal.

[0028] As shown in FIG. 1, a specific example of this pharmaceutical sales management system is configured as a program on a mobile terminal such as a tablet terminal, and can be a pharmaceutical sales management system 1 including a pharmacist identification information acquisition means 11, a pharmaceutical identification information acquisition means 21, an explanatory information acquisition means 22, an explanatory information presentation means 23, a presentation confirmation means 24, a sales target identification information acquisition means 25, and a history storage means 31. The system further includes a pharmacist database 12, a pharmaceutical database 26, a history database 32, and a barcode reading means 41. The pharmacist database 12 is a database that records the identification information of all pharmacists who are authorized to sell pharmaceuticals through this pharmaceutical sales management system. If the requested identification information is not included in the pharmacist database 12, it can be determined that the corresponding identification information is not authorized to sell the pharmaceutical. The pharmaceutical database 26 is a database that stores pharmaceutical identification information and corresponding pharmaceutical explanatory information. The pharmaceutical explanatory information is configured by combining one or more documents, such as a checklist document as shown in FIG. 2, pharmaceutical package inserts, and related images. As illustrated in Figure 3, the history database 32 is a database that records information such as the date and time of sale, identification information of the sold medicine (the name of the medicine in the item in Figure 3), the quantity of the medicine sold, confirmation of the time of purchase of the sold medicine, the name of the person to whom the medicine was sold (the name of the purchaser in the item in Figure 3), and pharmacist identification information (the name of the pharmacist in the item in Figure 3). A specific example will be described below with reference to the flowchart shown in FIG.

[0029] (1) Obtain pharmacist identification information (Step S01) This pharmaceutical sales management system first acquires the identification information of the pharmacist making the sale using pharmacist identification information acquisition means 11, according to the flowchart shown in Figure 5. Pharmacist identification information acquisition means 11 can acquire the pharmacist identification information in the form of a barcode printed on an information medium such as a nameplate carried by the pharmacist by reading it using barcode reading means 41 with the camera of the mobile terminal (see step S011). Furthermore, pharmacist identification information acquisition means 11 checks whether the acquired pharmacist identification information is recorded by referring to pharmacist database 12, which stores a list of pharmacist identification information (step S012). If the pharmacist identification information is recorded in pharmacist database 12, the corresponding pharmacist identification information is acquired and output to history storage means 31 (step S013).

[0030] (2) Acquire drug identification type (Step S02) Next, according to the flowchart shown in Figure 6, the drug identification information acquisition means 21 acquires the identification information of the drug to be sold. The drug identification information acquisition means 21 acquires drug identification information consisting of a product code attached to the packaging or the like of the drug to be sold by reading it using the barcode reading means 41 or the like (step S021). The acquired drug identification information is also used by the explanation information acquisition means 22 and the history storage means 31. If there are multiple drugs to be sold and there are unprocessed drugs remaining (see step S022), the drug identification information acquisition means 21 executes step S021 again to sequentially acquire the identification information of each drug using the barcode reading means 41. After acquiring the drug identification information for all drugs, the explanation information acquisition means 22 is executed.

[0031] (3) Obtaining drug description information (Step S03) 7, the explanatory information acquisition means 22 acquires explanatory information of the drug corresponding to the drug identification information acquired by the drug identification information acquisition means 21. The explanatory information acquisition means 22 queries the drug database 26 using the drug identification information acquired by the drug identification information acquisition means 21 as a key, and acquires explanatory information of the corresponding drug (step S031). If there are multiple drugs for sale and there is identification information for which corresponding drug description information has not been acquired, step S031 is performed again to acquire all of the drug description information corresponding to each drug (step S032). The description information acquisition means 22 passes all of the acquired drug description information to the description information presentation means 23.

[0032] (4) Present explanatory information (step S04) Next, the explanatory information presentation means 23, which has received all the drug explanatory information acquired by the explanatory information acquisition means 22, sequentially displays the drug explanatory information on a display means such as a touch panel display of the terminal. In addition, the explanatory information presentation means 23 processes the drug explanatory information so that it can be displayed on the display means when it is displayed. At this time, the pharmacist selling the product can present one or more pieces of displayed pharmaceutical information to the target customer and provide an explanation and guidance on the pharmaceutical product.

[0033] (5) Confirmation of presentation of explanatory information (step S05) 8, the explanatory information presentation means 23 displays the explanatory information for each drug, and then the presentation of the explanatory information is confirmed by the presentation confirmation means 24. The pharmacist asks the sales target to confirm the drug explanatory information. The sales target performs the confirmation operation by operating the confirmation button displayed on the touch panel display or the button on the terminal (step S051). The presentation confirmation means 24 detects that a confirmation operation has been performed, and if the operation is canceled without performing the confirmation operation, the sale is discontinued and no history is registered (step S052). Also, if unconfirmed drug description information remains, step S051 is performed again for the next drug description information (step S053). When the confirmation operation has been performed for all drug description information, the sales target identification information acquisition means 25 acquires sales target identification information. The sales target identification information acquisition means 25 acquires the sales target identification information by inputting the sales target's signature via the terminal's touch panel or by inputting the sales store's membership number (step S054), and then executes the history storage means 31.

[0034] (6) Recording sales history (Step S06) History storage means 31 acquires pharmacist identification information using pharmacist identification information acquisition means 11, acquires drug identification information using drug identification information acquisition means 21, acquires information on presentation confirmation of explanatory information using presentation confirmation means 24, and acquires target sales person identification information using target sales person identification information acquisition means 25. Then, sales history information including pharmacist identification information (pharmacist name in FIG. 3), drug identification information (drug name in FIG. 3), drug quantity information (quantity in FIG. 3) obtained by aggregating the input drug identification information, explanatory information confirmation (confirmation at the time of sale in FIG. 3), target sales person identification information (purchaser name in FIG. 3), and date and time of sale (current date and time) is recorded in history database 32 (see FIG. 3). The pharmaceutical quantity information is the quantity of pharmaceuticals sold. The pharmaceutical quantity information and the sales target identification information are obtained from the POS terminal used for the sale or from an input means such as a touch panel of the pharmaceutical sales management system 1.

[0035] In addition, as another specific example of this pharmaceutical sales management system, a pharmaceutical sales management system 1a will be described below, which includes, in addition to the components of the pharmaceutical sales management system 1 shown in Figure 1, a physical information database 33, a physical information display means 34, and a sales restriction means 35, as shown in Figure 9. The physical information database 33 is a database that stores the sales target person's identification information and physical information of the sales target person. It also stores information such as age as physical information. Furthermore, the pharmaceutical database 26 stores sales restriction information corresponding to the pharmaceutical identification information. The stored sales restriction information includes the age range for which sales are restricted and the details of the sales restriction. The details of the sales restriction also include details that restrict sales when the age included in the sales target person's physical information falls within the age range, or details that restrict sales only with parental consent.

[0036] (7) Information about the target seller The pharmaceutical sales management system 1a can display the physical information of the sales target person using the physical information display means 34. The physical information display means 34 is executed by operating the "Confirm personal data" button, which is an execution button of the physical information display means 34, that is displayed when the explanation information is confirmed and displayed by the presentation confirmation means 24 (step S05) (see FIG. 2). The physical information display means 34, which is executed by operating the button, acquires the sales target identification information using the sales target identification information acquisition means 25, as in step S054, and then acquires the physical information corresponding to the sales target identification information acquired using the physical information database 33. Next, the acquired physical information is displayed. After that, when an operation to end the display of the physical information is performed, the process returns to the confirmation display of the explanation information by the presentation confirmation means 24 (step S05).

[0037] (8) Sales Restrictions The pharmaceutical sales management system 1a can implement sales restrictions based on the physical information of the sales target person using the sales restriction means 35. The sales restriction means 35 is implemented after the confirmation display of the explanatory information by the presentation confirmation means 24 (step S05). As in step S054, sales restriction means 35 acquires sales target identification information using sales target identification information acquisition means 25. Thereafter, sales restriction means 35 acquires physical information corresponding to the acquired sales target identification information using physical information database 33. Furthermore, the sales restriction means 35 acquires sales restriction information corresponding to each piece of drug identification information from the drug database 26 . The system then compares the physical information with all the acquired restriction information to see if it applies, and if it does, displays that fact. Furthermore, the system can suspend sales or obtain parental consent in accordance with the content of the sales restrictions in the sales restriction information.

[0038] For example, if the pharmaceutical product is an emergency contraceptive, the sales restriction means 35 determines whether the age of the person in the physical information included in the restriction information is a minor. If the age is a minor, the means 35 then checks for parental consent. If parental consent is subsequently obtained, the means 35 continues sales and records the sales history. On the other hand, if consent is not obtained, the means 35 stops sales and notifies the person accordingly.

[0039] By performing the above procedure, this pharmaceutical sales management system 1 can store in a history database a one-to-one record of which pharmacist explained the pharmaceutical being sold, and can correctly manage the sales history of pharmaceutical instruction and sales by pharmacists.

[0040] The present invention is not limited to the specific embodiments described above, and various modifications can be made within the scope of the present invention depending on the purpose and application. [Explanation of symbols]

[0041] 1, 1a; Pharmaceutical sales management system, 11;Means for obtaining pharmacist identification information, 12;Pharmacist database, 21; drug identification information acquisition means, 22; explanation information acquisition means, 23; explanation information presentation means, 24; presentation confirmation means, 25; sales target identification information acquisition means, 26; drug database, 31; history storage means; 32; history database; 33; physical information database; 34; physical information display means; 35; sales regulation means; 41: Barcode reading means, 42: Identification information determining means.

Claims

1. a pharmacist identification information acquisition means for acquiring identification information of a pharmacist who provides instruction on the use of medicines; A drug identification information acquisition means for acquiring identification information of one or more of the drugs to be sold; an explanation information acquisition means for acquiring explanation information corresponding to the identification information of each drug obtained by the drug identification information acquisition means; an explanatory information presenting means for presenting the explanatory information of the drug acquired by the explanatory information acquiring means to a sales target of the drug; a presentation confirmation means for causing the target person to confirm the explanatory information of the drug presented by the explanatory information presentation means; a history storage means for recording sales history information in a history database, the sales history information including the drug identification information obtained by the drug identification information acquisition means, the sales date and time determined from the current date and time, and the pharmacist identification information obtained by the pharmacist identification information acquisition means, after the confirmation operation of the explanatory information by the presentation confirmation means is performed; and A pharmaceutical sales management system comprising:

2. The pharmaceutical sales management system according to claim 1, wherein the pharmaceutical identification information acquisition means acquires the pharmaceutical identification information by a barcode reading means that reads a barcode on which the pharmaceutical identification information is recorded and that is attached to the pharmaceutical.

3. 2. The pharmaceutical sales management system according to claim 1, wherein the pharmacist identification information acquisition means acquires the pharmacist's identification information by a barcode reading means that reads a barcode held by the pharmacist and on which the pharmacist's identification information is recorded.

4. 2. The pharmaceutical sales management system of claim 1, further comprising a sales target identification information acquisition means for acquiring identification information of the sales target, and wherein the history storage means records the sales history information including the sales target identification information acquired by the sales target identification information acquisition means in the history database.

5. 5. The pharmaceutical sales management system according to claim 4, wherein the identification information of the sales target is an identification number of a member of a store that sells pharmaceuticals.

6. the explanation information presenting means, when reading the identification information of the medicine by the barcode reading means, determines whether the identification information of the pharmacist has been read; The pharmaceutical sales management system according to claim 3, wherein if the information has been read, the information on the pharmacist is presented to the sales target together with the pharmaceutical explanation information.

Images